188Re-SSS Lipiodol

N/A

Report date: 2025/08/09 20:00:10

NME

Base Information

Drug Name188Re-SSS Lipiodol

Drug Alias NameN/A

ClassificationRadiation-emitting products

Mechanisms of ActionUpdating

TargetsNot applicable

Therapy Area/IndicationsCarcinoma, Hepatocellular

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCenter Eugene Marquis

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCenter Eugene Marquis

Active IndicationsN/A

Inactive IndicationsCarcinoma, Hepatocellular

Other Information

ATC CodeN/A

Related LinksN/A